Literature DB >> 34164596

Neuroenhancement for sale: assessing the website claims of neurofeedback providers in the United States.

Anna Wexler1, Ashwini Nagappan1, Deena Kopyto1, Rebekah Choi1.   

Abstract

Although electroencephalographic (EEG) neurofeedback is a technique that has been in existence for many decades, it has remained controversial, largely due to questions about efficacy. Yet neurofeedback is being widely offered to the public, often at great expense. To date, however, there has not been empirical data on which providers are utilizing neurofeedback, what they are offering it for, and how they are advertising the technique. The present study aimed to fill that gap by systematically analyzing the websites of neurofeedback practitioners in the United States. To that end, we obtained data from four directories of neurofeedback providers, extracting practitioner names, geographical locations, professional training, and website URLs. Only websites offering neurofeedback services (N=371) were included in the next step, wherein two coders independently coded the websites based on a codebook developed from preliminary analyses. We found that nearly all websites (97.0%) contained claims about at least one clinical indication, most commonly anxiety, ADHD/ADD, and depression; however, only 36.0% of providers had either a medical degree (MD) or a doctoral-level degree in psychology. The majority of websites advertised neurofeedback for cognitive (90.0%) or performance (67.9%) enhancement, and roughly three-quarters utilized language related to complementary and alternative medicine (CAM). In sum, there is a considerable divergence between the scientific literature on neurofeedback and the marketing of neurofeedback services to the general public, raising concerns regarding the misrepresentation of services and misleading advertising claims.

Entities:  

Keywords:  EEG; cognitive enhancement; neuroethics; neurofeedback; neuroscience and society

Year:  2020        PMID: 34164596      PMCID: PMC8218893          DOI: 10.1007/s41465-020-00170-8

Source DB:  PubMed          Journal:  J Cogn Enhanc        ISSN: 2509-3304


  4 in total

1.  Brain Wellness "Spas"-Anticipating the Off-label Promotion of Psychedelics.

Authors:  Anna Wexler; Dominic Sisti
Journal:  JAMA Psychiatry       Date:  2022-08-01       Impact factor: 25.911

2.  Neurofeedback as placebo: a case of unintentional deception?

Authors:  Louiza Kalokairinou; Laura Specker Sullivan; Anna Wexler
Journal:  J Med Ethics       Date:  2021-09-14       Impact factor: 5.926

3.  Opportunity Cost or Opportunity Lost: An Empirical Assessment of Ethical Concerns and Attitudes of EEG Neurofeedback Users.

Authors:  Louiza Kalokairinou; Rebekah Choi; Ashwini Nagappan; Anna Wexler
Journal:  Neuroethics       Date:  2022-09-23       Impact factor: 1.427

Review 4.  Ethical and Legal Considerations of Alternative Neurotherapies.

Authors:  Ashwini Nagappan; Louiza Kalokairinou; Anna Wexler
Journal:  AJOB Neurosci       Date:  2021-03-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.